EE+ POEM Archive
No reduction in mortality with continuous vs intermittent infusion of beta-lactam antibiotics for critically ill patients with sepsis (BLING-III)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "No Reduction in Mortality With Continuous Vs Intermittent Infusion of Beta-lactam Antibiotics for Critically Ill Patients With Sepsis (BLING-III)." EE+ POEM Archive, John Wiley & Sons, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377219/all/No_reduction_in_mortality_with_continuous_vs_intermittent_infusion_of_beta_lactam_antibiotics_for_critically_ill_patients_with_sepsis__BLING_III_.
No reduction in mortality with continuous vs intermittent infusion of beta-lactam antibiotics for critically ill patients with sepsis (BLING-III). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2024. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377219/all/No_reduction_in_mortality_with_continuous_vs_intermittent_infusion_of_beta_lactam_antibiotics_for_critically_ill_patients_with_sepsis__BLING_III_. Accessed December 3, 2024.
No reduction in mortality with continuous vs intermittent infusion of beta-lactam antibiotics for critically ill patients with sepsis (BLING-III). (2024). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377219/all/No_reduction_in_mortality_with_continuous_vs_intermittent_infusion_of_beta_lactam_antibiotics_for_critically_ill_patients_with_sepsis__BLING_III_
No Reduction in Mortality With Continuous Vs Intermittent Infusion of Beta-lactam Antibiotics for Critically Ill Patients With Sepsis (BLING-III) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2024. [cited 2024 December 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377219/all/No_reduction_in_mortality_with_continuous_vs_intermittent_infusion_of_beta_lactam_antibiotics_for_critically_ill_patients_with_sepsis__BLING_III_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - No reduction in mortality with continuous vs intermittent infusion of beta-lactam antibiotics for critically ill patients with sepsis (BLING-III)
ID - 3377219
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377219/all/No_reduction_in_mortality_with_continuous_vs_intermittent_infusion_of_beta_lactam_antibiotics_for_critically_ill_patients_with_sepsis__BLING_III_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
